ArticleOphthalmology science
Estimated Rates of Retinal Ganglion Cell Loss with Aging.
Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optical coherence tomography and electroretinography in pituitary macroadenomas: a 12-month analysis by age and tumor type.Frontiers in endocrinology · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Purpose: To evaluate the effect of aging on estimated retinal ganglion cell (RGC) counts over time in healthy eyes, obtained from a combination of structural and functional information. Design: Longitudinal observational cohort study. Participants: One hundred healthy eyes of 50 subjects. Methods: Estimated RGC counts were obtained by a previously described method using standard automated perimetry sensitivity thresholds and OCT retinal nerve fiber layer thickness measurements. Linear mixed-effects models were applied to investigate the effect of aging, as well as other covariates, on rates of change in estimated RGC counts over time. Main Outcome Measures: Rates of change in estimated RGC counts in healthy eyes. Results: Subjects had a mean age of 49.6 ± 15.7 years at baseline (range 22.8-89.9 years) and were followed up for 3.5 ± 2.5 years. Thirty-three (66%) patients were female and 11 (22%) self-identified as Black. At baseline, the eyes had an average estimated RGC count of 1 144 010 ± 222 084 cells. After adjusting for confounding factors, the mean rate of change in estimated RGC counts was -6769 RGC/year (95% confidence interval: -10 994 to -2544 RGC/year; Conclusions: A significant age-related decline in estimated RGC counts was found in healthy subjects with a combined metric integrating imaging and functional testing. The estimated mean age-related decline was remarkably similar to estimates from previous histologic studies in cadaver eyes, reinforcing the validity of the proposed combined metric and highlighting the importance of considering age when evaluating RGC count changes over time for monitoring glaucoma progression. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.